Showing results (361-370 of 456) with videos related to

Sort By:
Pageof 46
Journal of Biomedical Materials Research. Part A|March 27, 2018
Self-assembled, ellipsoidal polymeric nanoparticles for intracellular delivery of therapeuticsPrachi Desai, Anjana Venkataramanan, Rebecca Schneider, et al.
Health Economics|July 21, 2023
Modeled health economic and equity impact on dental caries and health outcomes from a 20% sugar sweetened beverages tax in AustraliaTan Minh Nguyen, Utsana Tonmukayakul, Long Khanh-Dao Le, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 7, 2016
Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune responseSwapnil S Bawage, Pooja M Tiwari, Ankur Singh, et al.
Indian Journal of Pediatrics|October 28, 2016
I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular DiagnosisAnkur Singh, Rajniti Prasad, Aditya Kumar Gupta, et al.
BMC Public Health|November 7, 2024
Effectiveness of behaviour change techniques in lifestyle interventions for non-communicable diseases: an umbrella reviewIliatha Papachristou Nadal, Chaisiri Angkurawaranon, Ankur Singh, et al.
Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.
Cytotherapy|February 22, 2022
Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipidsS'Dravious A DeVeaux, Molly E Ogle, Sofiya Vyshnya, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2013
Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell linesYongzhong Wu, Jiamo Lu, Smitha Antony, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationS'Dravious A DeVeaux, Daniel C Shah, Keji Rui, et al.
Frontiers in Immunology|March 26, 2021
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A VirusBrock Kingstad-Bakke, Randall Toy, Woojong Lee, et al.
Pageof 46